Contraception for women with health problems

International Journal of Fertility and Menopausal Studies

Volumn 41, Issue 2, 1996, Pages 77-84

  Corson, Stephen L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

cardiovascular disease; coagulopathies; diabetes mellitus; dyslipidemia; endocrinopathies; epilepsy; migraine; oral contraceptives

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DRUG SAFETY; DYSLIPIDEMIA; ENDOCRINE DISEASE; EPILEPSY; FEMALE; HUMAN; HYPERTENSION; MIGRAINE; OBESITY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR;

BLOOD COAGULATION DISORDERS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DIABETES MELLITUS; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; HYPERLIPIDEMIAS; NERVOUS SYSTEM DISEASES; RISK FACTORS; WOMEN'S HEALTH;

EID: 0030004603     PISSN: 10693130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Tsai C: Low-dose oral contraception and blood pressure in women with a past history of elevated blood pressure. Am J Obstet Gynecol 151:28-32, 1985.
2. Elam MB, Viar MJ, Ratts TF, et al: Mitral valve prolapse in women with oral contraceptive-related cerebrovascular insufficiency. Associated persistent hypercoagulable state. Arch Intern Med 146:73, 1986.
3. Stampfer MJ, Willett WC, Colditz GA, et al: A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 319:1313-1317, 1988.
4. Sullivan JM, Lobo RA: Considerations for contraception in women with cardiovascular disorders. Am J Obstet Gynecol 168:2006, 1993.
5. Engel HJ, Engel E, Lichtlen PR: Coronary atherosclerosis in young women-role of contraceptives. Eur Heart J 4:1-6, 1983.
6. Speroff L, DeCherney A, Burkman RT, Jr, et al: Evaluation of a new generation of oral contraceptives. Obstet Gynecol 81:1034-1047, 1993.
7. Darney PD, Klaisle CM, Tanner S, et al: Sustained-release contraceptives. Cuir Prob Obstet Gynecol Fertil 13:87, 1990.
8. Fahraeus L, Sydsjo A, Wallentin L: Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate. Fertil Steril 45:503-506, 1986.
9. Meade TW: Fibrinogen and other clotting factors in cardiovascular disease, in Francis RB, Jr (ed): Atherosclerosis, Cardiovascular Disease, Hemostasis and Endothelial Function. New York, Marcel Dekker, Inc., pp 1-34, 1992.
10. Comp PC, Esmon C: Regulatory mechanisms and hemostasis: Natural anticoagulants, in Hoff man R, Benz ES, Shattil SJ, et al (eds): Hematology: Basic Principles in Practice. New York, Churchill Livingstone, pp 1243-1251, 1991.
11. Gerstman BB, Piper JM, Tomita DK, et al: Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol 133:32-37, 1991.
12. Comp PC, Zacur HA: Contraceptive choices in women with coagulation disorders. Am J Obstet Gynecol 168:1990, 1993.
13. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1039-1057, 1979.
14. Coustan DR, Nelson C, Carpenter NW, et al: Maternal age and screening for gestational diabetes: A population based study. Obstet Gynecol 73:557-561, 1989.
15. Manson JE, Rimm EB, Stampfer MK, et al: Physical activity and incidence of non-insulin dependent diabetes mellitus in women. Lancet 338:774-778, 1991.
16. Klein BE, Moss SE, Klein R: Oral contraceptives in women with diabetes. Diabetes 138:895-898, 1990.
17. Shoupe D, Kjos S. Effects of oral contraceptives on the borderline NIDD patient. Int J Fertil 33(suppl):27-34, 1988.
18. Skouby SO, Malsted-Pedersen L, Petersen KR: Contraception for women with diabetes: An update. Clin Obstet Gynecol 5:493-503, 1991.
19. Kjor SL, Shoupe D, Douyan S, et al: Effect of low dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: Results of a controlled randomized prospective study. Am J Obstet Gynecol 163:1822-1827, 1990.
20. Skouby SO, Malsted-Pedersen L, Kühl C, et al: Oral contraceptives in diabetic women: Metabolic effects of compounds with different estrogen/progestogen profiles. Fertil Steril 46:858-864, 1986.
21. Gosden C, Steel J, Ross A, et al: Intrauterine contraceptive devices in diabetic women. Lancet 1:530-535, 1982.
22. Skouby SO, Malsted-Pedersen L, Kasonen A: Consequences of intrauterine contraception in diabetic women. Fertil Steril 42:568-572, 1984.
23. Mestman JH, Schmidt-Sarosi C: Diabetes mellitus and fertility control: Contraception management issues. Am J Obstet Gynecol 168:2012-2020, 1993.
24. The Pituitary Adenoma Study Group: Pituitary adenomas and oral contraceptives: A multicentric- controlled study. Pertü Steril 39:753-761, 1983.
25. Shey KK, McTiernan AM, Galling JR, et al: Oral contraceptive use and the occurrence of pituitary prolactinoma. JAMA 249:2204-2207, 1983.
26. Ramcharan S, Pellegrin FA, Ray RM, et al: The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. J Reprod Med 25:345-372, 1980.
27. Mattson RH, Cramer JC, Caldwell BV, et al: Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology 34: 1255-1258. 1984.
28. Mattson RH, Cramer JC, Darney PC, et al: Use of oral contraceptives by women with epilepsy. JAMA 256:238-240, 1986.